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Transient Xist-ence Minireview
Mitzi I. Kuroda and Victoria H. Meller* well as transcript accumulation were qualitatively exam-
ined; (2) nuclear runoff experiments, in which the tran-Howard Hughes Medical Institute
scription rate was compared between cells that accu-Department of Cell Biology
mulate Xist RNA (such as female somatic cells) and cellsBaylor College of Medicine
that do not (such as male ES cells); and (3) pulse±chaseHouston, Texas 77030
experiments, in which the half-life of Xist RNA was com-
pared in those same populations. The conclusions
reached were that if one X is selected to be active, it
Ever since X inactivation was first postulated as the must somehow retain the ability to rapidly degrade its
mechanism of dosage compensation in mammals (Lyon, own Xist RNA, while all other X chromosomes in the
1961), a central question has been how homologous X cell accumulate their Xist transcripts. Stable Xist RNA
chromosomes could coexist in the same nucleus with associates with its X chromosome of origin to somehow
one in a transcriptionally active state (Xa), and the other establish an inactive chromatin state, while failure of
inactive (Xi). Once established, it was not too difficult Xist to accumulate preserves a transcriptionally active
to imagine that the active or inactive state could be state. This initial decision becomes locked in by the
propagated by, for example, heritable modification of subsequent silencing of Xist at the transcriptional level
the DNA of the inactive chromosome. But how to estab- on Xa, a process dependent upon DNA methylation
lish the initial states? The most remarkable characteris- (Beard et al., 1995; Panning and Jaenisch, 1996).
tic of X inactivation is that, if challenged with extra cop- Thus, X inactivation follows a classic two-step pro-
ies of the X chromosome, all but one X in a given cell cess to establish one of two developmental fates (Figure
will be inactivated. A discrete region of the X, the X 1). Initially, the two X chromosomes appear identical,
inactivation center (Xic), is required for both counting until threshold conditions are met in which one X will
and X inactivation (for review, see Willard, 1996; Lee follow a different developmental pathway from the other.
and Jaenisch, 1997a). However, hovering near a threshold is inherently an un-
The only known participant in X inactivation is Xist stable situation. Therefore, after the initial develop-
RNA, a remarkable molecule originating from the Xic. mental decision is made, it is locked in place by a stable,
Although its structure resembles that of a messenger self-perpetuating state that renders the original signal
RNA (it is large, alternatively spliced, and polyadeny- irrelevant. In the case of X inactivation, the initial signal
lated), it does not encode a protein, but instead acts in results in labile Xist RNA transcribed from the future Xa
the nucleus to mediate mammalian dosage compensa- chromosome in the same nucleus in which all other X
tion. Xist RNA is essential for inactivation of most genes chromosomal Xist is stabilized. A second step must
along the X chromosome in female mammals (Penny et occur, however, to protect the status of the Xa later in
al., 1996; Marahrens et al., 1997). Early in the develop- development. The Xist transcription from Xa must be
ment of female embryos, the paternal X chromosome silenced, as the original signal (the ability to destablilize
(Xp) is selectively inactivated in the extraembryonic tis- Xist RNA) appears to be transient.
sues, while one of the two X chromosomes is randomly The evidence that destabilization of Xist is transient
inactivated in the embryo proper. Accumulation of Xist comes from analyses of methylation-defective embryos
transcripts along the length of the chromosome appears (Panning and Jaenisch, 1996). In the absence of methyl-
to be an essential step in chromosome inactivation. A ation, Xist transcription from the Xa continues when it
defining characteristic of Xist RNA is that it appears normally would be silenced. In these mutants, nuclei in
to function strictly in cis, by associating only with the both male and female embryos can be observed with
chromosome from which it originates (Clemson et al., all X chromosomes in an inactive configuration, covered
1996; Lee et al., 1996; Herzing et al., 1997; Lee and with Xist RNA. This result suggests that as development
Jaenisch, 1997b). proceeds, Xist destabilization factors can no longer pro-
The selection of one X to be active and the other to tect active X chromosomes from Xist. Furthermore, any
accumlate Xist RNA and to be inactive is still a deep stabilization factors involved are not in limiting amounts
mystery. However, a major step forward comes from and are not even sex-specific.
the discovery that the choice is manifestedby thestabili- What could be the signal that initially protects one
zation of Xist RNA transcribed from the inactive X chro- and only one X chromosome from Xist accumulation?
mosome, rather than transcriptional up-regulation of It is possible that the crucial difference lies in the Xist
transcript itself. Both Panning et al. (1997) and Shear-Xist. The stabilizationof Xist RNA from the future inactive
down et al. (1997) attempt to determine whether theX is concurrent with the persistent turnover of Xist RNA
primary structures of stable and unstable Xist RNAs aretranscribed from the X that will remain active (Panning
identical. Neither group detects any differences be-et al., 1997; Sheardown et al., 1997 [this issue of Cell]).
tween the two, although this is a difficult question toThese conclusions were based on (1) in situ hybridiza-
answer with certainty using RT±PCR. If the RNAs aretion of early embryos, in which nascent transcription as
indeed the same, we are left to imagine how the active
X could be physically sequestered from otherwise ubiq-
uitous Xist RNA stabilization factors. Alternatively, there*Present address: Department of Biology, Tufts University, Medford,
Massachusetts 02155. might be limiting amounts of proteins that counteract
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Figure 1. Two-Step Model for Establishment
of Stable X Inactivation
Large circles represent individual nuclei sub-
jected to Xist RNA in situ hybridization. Black
dots within nuclei represent sites of Xist RNA
transcription, while larger black ovals repre-
sent stable Xist RNA accumulation.
stabilization factors, which are exquisitely cooperative 1. Eight-cell female embryos already have one chromo-
some that displays high Xist accumulation in all nuclei,such that they assemble on only one site of Xist produc-
tion per nucleus. One of the more striking conclusions while eight-cell male embryos have only low-level Xist
expression or display no Xist signal (Figure 2). The au-that can be drawn about the establishment of only one
active X chromosome is that the process appears to thors do not identify which X chromosome accumulates
Xist in female embryos at this early developmental stage.require no sex-specific components. This makes some
biological sense, as sex determination is not directly However, one interpretation, consistent with previous
studies (Kay et al., 1993, 1994), is that Xist accumulatescoupled to X chromosome number in mammals. What-
ever counts one active X chromosome does so in both from Xp, which is not inherited by male embryos. Xp is
thought to be imprinted during spermatogenesis, as itmale and female nuclei, the only difference being that
females have an additional X chromosome available for is nonrandomly inactivated in extraembryonic tissues
(trophectoderm). The in situ data suggest that the im-Xist RNA accumulation (Figure 1).
A dramatic transition in Xist RNA stability may happen print of Xp correlates with the ability to express and
accumulate the Xist transcript. In trophectoderm, thatmore than once during early development. In addition
to examining embryos at the time that random X inacti- status would be maintained, resulting in exclusively pa-
ternal X inactivation. However, in the embryo proper (thevation is established (between 5.5 and 8.5 dpc), Shear-
down et al. (1997) also performed in situ analysis of inner cell mass), the paternal Xist accumulation must
be reversed (Figure 2), in order for X inactivation to occureight-cell embryos (2.5 dpc), several days prior to X
inactivation in the embryo. Their findings suggest that randomly a few days later (as in Figure 1). To accomplish
this, the molecules that function in the destruction ofthe status of Xist RNA is more dynamic during develop-
ment than the three-stage model considered in Figure Xist RNA must be exquisitely regulated, both spatially
Figure 2. Model for Imprinting of the Paternal
X Chromosome in Spermatogenesis, and Its
Subsequent Erasure in the Inner Cell Mass in
Early Development
Black dots withinnuclei represent sites of Xist
RNA transcription, while larger black ovals
represent stable Xist RNA accumulation. Xp,




Panning, B., Dausman, J., and Jaenisch, R. (1997). Cell 90, 907±916.and temporally, during development. The challenge for
Penny, G.D., Kay, G.F., Sheardown, S.A., Rastan, S., and Brockdorff,the future will be to identify the key regulators of Xist
N. (1996). Nature 379, 131±137.RNA, which should reveal the mechanism of chromo-
Sheardown, S.A., Duthie, S.M., Johnston, C.M., Newall, A.E.T.,some choice.
Formstone, E.J., Arkell, R.M., Nesterova, T.B., Alghisi, G.-C., Rastan,Examination of other model organisms has revealed
S., and Brockdorff, N. (1997). Cell 91, this issue, 99±107.alternate strategies for dealing with dosage imbalance
Willard, H.F. (1996). Cell 86, 5±7.of the sex chromosomes (for reviews, see Kelley and
Kuroda, 1995; Cline and Meyer, 1996). For example,
dosage compensation occurs by increased transcrip-
tion of the X chromosome in male Drosophila, rather
than X inactivation in females. Since the dosage-com-
pensated X has no homolog in male nuclei, there is no
selection process comparable to the choice between
the two female chomosomes in mammalian X inactiva-
tion. Nevertheless, there are unanticipated parallels be-
tween dosage compensation in mammals and Drosoph-
ila. In both systems dosage compensation involves
modified chromatin architecture. The most intriguing
parallel is that the dosage-compensated X chromosome
in Drosophila is also coated with one or more large,
noncoding, polyadenylated RNAs called roX (RNA on X)
(Amrein and Axel, 1997; Meller et al., 1997). The function
of roX RNAs has not been determined. However, their
synthesis or accumulation is strictly dependent on the
known mediators of dosage compensation in Drosoph-
ila, the MSL proteins, which themselves coat the X chro-
mosome. Colocalization of roX RNAs with the proteins
that regulate them raises the possibility that they are
also controlled at the level of RNA stability.
No proteins have yet been reported to participate in
mammalian X inactivation. The hypothetical molecules
that render Xist RNA stable are intriguing, as stabiliza-
tion factors are likely to assemble with Xist RNA on the
inactive X chromosome and thus could play a direct role
in the biochemical mechanismof X inactivation. As these
factors are identified in the coming years, we can expect
far greater insights into the fascinating question of how
chromatin-associated RNAs may control global changes
in chromatin architecture.
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